Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 1716
117th Congress(2021-2022)
COVID–19 Mental Health Research Act
Introduced
Introduced
Introduced in House on Mar 9, 2021
Overview
Text
Introduced in House 
Mar 9, 2021
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Mar 9, 2021)
Mar 9, 2021
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 1716 (Introduced-in-House)


117th CONGRESS
1st Session
H. R. 1716


To direct the Secretary of Health and Human Services, acting through the Director of the National Institute of Mental Health, to conduct or support research on the mental health consequences of SARS–CoV–2 or COVID–19, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

March 9, 2021

Mr. Tonko (for himself, Mr. Katko, Mr. Cárdenas, Mr. Rodney Davis of Illinois, Ms. Dean, Mr. Fitzpatrick, Mrs. Hayes, Mr. Lowenthal, Mr. Levin of California, Mr. Meeks, Ms. Meng, Mr. Nadler, Mrs. Napolitano, Mr. Payne, Mr. Suozzi, Ms. Strickland, and Mrs. Watson Coleman) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To direct the Secretary of Health and Human Services, acting through the Director of the National Institute of Mental Health, to conduct or support research on the mental health consequences of SARS–CoV–2 or COVID–19, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “COVID–19 Mental Health Research Act”.

SEC. 2. RESEARCH ON THE MENTAL HEALTH IMPACT OF COVID–19.

(a) In general.—The Secretary of Health and Human Services (in this section referred to as the “Secretary”), acting through the Director of the National Institute of Mental Health, shall conduct or support research on the mental health consequences of SARS–CoV–2 or COVID–19.

(b) Use of funds.—Research under subsection (a) may include—

(1) research on the mental health impact of SARS–CoV–2 or COVID–19 on health care providers, including—

(A) traumatic stress;

(B) psychological distress; and

(C) psychiatric disorders; and

(2) research on the impact of SARS–CoV–2 or COVID–19 stressors on mental health over time;

(3) research to strengthen the mental health response to SARS–CoV–2 or COVID–19, including adapting to and maintaining or providing additional services for new or increasing mental health needs;

(4) research on the reach, efficiency, effectiveness, and quality of digital mental health interventions;

(5) research on the effectiveness of strategies for implementation and delivery of evidence-based mental health interventions and services for underserved populations;

(6) research on suicide prevention; and

(7) research on the impact of SARS–CoV–2 or COVID–19 on the mental health of children and adolescents.

(c) Research coordination.—The Secretary shall coordinate activities under this section with similar activities conducted by national research institutes and centers of the National Institutes of Health to the extent that such institutes and centers have responsibilities that are related to the mental health consequences of SARS–CoV–2 or COVID–19.

(d) Authorization of appropriations.—To carry out this section, there is authorized to be appropriated $100,000,000 for each of fiscal years 2022 through 2026, to remain available until expended.